Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China flag China · Delayed Price · Currency is CNY
35.57
-1.41 (-3.81%)
Nov 13, 2026, 3:00 PM CST

SHA:688091 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
69.6964.566.98161.55142.85-4
Depreciation & Amortization
11.9911.9911.167.886.436.59
Other Amortization
2.12.10.70.3-0.56
Asset Writedown & Restructuring Costs
-0.02-----
Loss (Gain) From Sale of Investments
-7.13-7.17-9.69-7.52-12.89-5.44
Provision & Write-off of Bad Debts
14.15-5.065.432.030.22
Other Operating Activities
47-11.62-12.97-26.94-18.33-5.81
Change in Accounts Receivable
-81.94-81.9485-69.19-28.46-21.5
Change in Inventory
-18.64-18.64-16.73-11.38-5.28-10.3
Change in Accounts Payable
20.6220.62-17.430.4217.72-3.81
Operating Cash Flow
41.24-19.3839.4486.55110.78-48.78
Operating Cash Flow Growth
---54.44%-21.87%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-58.45-130.09-80.04-8.78-35.88-3.14
Sale of Property, Plant & Equipment
0-0---
Investment in Securities
-440-450-13586511.29-788.74
Other Investing Activities
807.576.4322.3939.2726.866.25
Investing Cash Flow
309.12-573.65-192.65116.49502.27-785.63

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
---44-16.75
Long-Term Debt Issued
-259.1---
Total Debt Issued
25259.144-16.75
Short-Term Debt Repaid
---53.1--16.75-3.25
Total Debt Repaid
---53.1--16.75-3.25
Net Debt Issued (Repaid)
2525-4444-16.7513.5
Issuance of Common Stock
5.092.5918.77--1,008
Repurchase of Common Stock
-35-35-37.24---
Common Dividends Paid
-0.42-0.07-49.79-43.41-0.49-
Other Financing Activities
-26.53-----76.59
Financing Cash Flow
-31.85-7.48-112.270.59-17.24944.65

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
318.51-600.52-265.48203.64595.82110.24

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-17.21-149.47-40.677.7774.9-51.93
Free Cash Flow Growth
---3.83%--
Free Cash Flow Margin
-5.28%-47.29%-23.40%21.59%31.74%-1273.49%
Free Cash Flow Per Share
-0.08-0.74-0.170.490.36-0.33
Levered Free Cash Flow
-534.98-167.25-30.355.2233.72-50.68
Unlevered Free Cash Flow
-534.94-167.21-29.8655.3933.72-50.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
-----0.59
Cash Income Tax Paid
10.953.9323.8932.97-0.880.49
Change in Working Capital
-83.38-83.3848.32-54.15-9.31-40.9